Case Study: Leading Global Pharmaceutical Company achieves 14-week early enrollment with IQVIA

IQVIA™ Biotech’s patient recruitment process and predictive enrollment expertise can dramatically reduce enrollment timelines

Leading Global Pharmaceutical Company, a dermatology-focused sponsor, engaged IQVIA (via IQVIA Biotech) to manage patient recruitment for a large Phase III psoriasis trial across 60 sites with a goal of randomizing 1,152 patients. The sponsor faced the common challenge of site under-enrollment and had planned a 32‑week enrollment period (nine months); IQVIA was tasked with meeting the enrollment target on schedule.

IQVIA deployed its patient recruitment process and predictive enrollment expertise—running a tailored national advertising campaign, concentrating spend in the first three months, and continuously adjusting based on enrollment metrics. The result: enrollment was completed in 18 weeks (14 weeks ahead of plan), the timeline was reduced by 44%, the budget was maintained, and IQVIA delivered 62% of all enrolled patients (sites contributed 38%).